Paper356569
Spironolactone.
Ochs HR and 3 others. Am Heart J, 1978. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Spironolactone. Papers, record 356569. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356569
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Spironolactone | Major topic |
| Androgen Antagonists | |
| Animals | |
| Blood Pressure | |
| Chemical Phenomena | |
| Chemistry | |
| Drug Antagonism | |
| Enzyme Induction | |
| Enzyme Repression | |
| Humans | |
| Microsomes, Liver | |
| Myocardial Contraction | |
| Respiration | |
| Salicylates | |
| Water-Electrolyte Balance |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39925732 | A perspective on small molecules targeting the renin-angiotensin-aldosterone system and their utility in cardiovascular diseases: exploring the structural insights for rational drug discovery and development. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/39925732 | PubMed |
| 38068758 | An Update on Drug-Nutrient Interactions and Dental Decay in Older Adults. | Nutrients | 2023 | https://conductscience.org/library/papers/38068758 | PubMed |
| 37847437 | The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances. | Clin Exp Nephrol | 2024 | https://conductscience.org/library/papers/37847437 | PubMed |
| 33067334 | Guidelines on the management of ascites in cirrhosis. | Gut | 2021 | https://conductscience.org/library/papers/33067334 | PubMed |
| 29226122 | Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity? | Front Med (Lausanne) | 2017 | https://conductscience.org/library/papers/29226122 | PubMed |
| 23403436 | Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials. | Circ Heart Fail | 2013 | https://conductscience.org/library/papers/23403436 | PubMed |
| 23105506 | Effect of spironolactone on acid and alkaline phosphatase in the testes of albino rat. | Indian J Clin Biochem | 2005 | https://conductscience.org/library/papers/23105506 | PubMed |
| 22081497 | Spironolactone and colitis: increased mortality in rodents and in humans. | Inflamm Bowel Dis | 2012 | https://conductscience.org/library/papers/22081497 | PubMed |
| 9009126 | Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea. | Dig Dis Sci | 1997 | https://conductscience.org/library/papers/9009126 | PubMed |
| 7795556 | Corticosteroid receptor antagonists: a current perspective. | Pharm World Sci | 1995 | https://conductscience.org/library/papers/7795556 | PubMed |
| 7333059 | Pharmacokinetics of metoprolol in patients with hepatic cirrhosis. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/7333059 | PubMed |
| 7332740 | Quantitative comparison of aldosterone antagonists in normal human subjects: prediction of therapeutic potency. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7332740 | PubMed |
| 7295494 | Comparison of single and divided daily dose spironolactone in the control of hypertension. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7295494 | PubMed |
| 7066166 | Spironolactone dose-response relationships in healthy subjects. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7066166 | PubMed |
| 7056270 | Systolic time intervals during spironolactone treatment of digitalized and non-digitalized patients with ischaemic heart disease. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7056270 | PubMed |
| 7035184 | Effect of spironolactone on systemic blood pressure, limb blood flow and response to sympathetic stimulation in hypertensive patients. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7035184 | PubMed |
| 7032875 | Resistance to diuretics: emphasis on a pharmacological perspective. | Drugs | 1981 | https://conductscience.org/library/papers/7032875 | PubMed |
| 6849751 | The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6849751 | PubMed |
| 6460516 | Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6460516 | PubMed |
| 6406259 | Effect of spironolactone on p-nitrophenol glucuronidation in isolated rat hepatocytes. | Experientia | 1983 | https://conductscience.org/library/papers/6406259 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/356569
GET https://conductscience.org/api/papers/v1/356569/cited_by?page=2